Patents by Inventor Hollie Wayment

Hollie Wayment has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7449338
    Abstract: The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: November 11, 2008
    Assignee: Ischemia Technologies, Inc.
    Inventors: David Bar-Or, Edward Lau, James V. Winkler, Gary Fagan, Hollie Wayment
  • Publication number: 20060191788
    Abstract: The subject invention comprises electrochemical methods and devices for in vitro detection of an ischemic event in a patient sample. Following addition of a known amount of a transition metal ion to the patient sample, electrodes are used to measure the current or potential difference of non-sequestered transition metal ion in the sample. The amount of non-sequestered transition metal ion in the sample reflects the degree of modification to albumin that is the result of an ischemic event.
    Type: Application
    Filed: May 1, 2006
    Publication date: August 31, 2006
    Applicant: Ischemia Technologies, Inc.
    Inventors: Hollie Wayment, Gary Fagan, Peter Crosby, Shannon George
  • Patent number: 7063782
    Abstract: The subject invention comprises electrochemical methods and devices for in vitro detection of an ischemic event in a patient sample. Following addition of a known amount of a transition metal ion to the patient sample, electrodes are used to measure the current or potential difference of non-sequestered transition metal ion in the sample. The amount of non-sequestered transition metal ion in the sample reflects the degree of modification to albumin that is the result of an ischemic event.
    Type: Grant
    Filed: November 26, 2002
    Date of Patent: June 20, 2006
    Assignee: Ischemia Technologies, Inc.
    Inventors: Hollie Wayment, Gary Fagan, Peter A. Crosby, Shannon George
  • Publication number: 20050142613
    Abstract: The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event.
    Type: Application
    Filed: January 12, 2005
    Publication date: June 30, 2005
    Inventors: David Bar-Or, Edward Lau, James Winkler, Gary Fagan, Hollie Wayment
  • Publication number: 20030180820
    Abstract: The present invention relates to rapid methods for the detection of ischemic states and to kits for use in such methods. Provided for is a rapid method of testing for and quantifying ischemia based upon methods of detecting and quantifying the existence of an alteration of the serum protein albumin which occurs following an ischemic event; methods for detecting and quantifying this alteration include evaluating and quantifying the cobalt binding capacity of circulating albumin, analysis and measurement of the ability of serum albumin to bind exogenous cobalt, detection and measurement of the presence of endogenous copper in a purified albumin sample and use of an immunological assay specific to the altered form of serum albumin which occurs following an ischemic event.
    Type: Application
    Filed: December 13, 2002
    Publication date: September 25, 2003
    Inventors: David Bar-Or, Edward Lau, James V. Winkler, Gary Fagan, Hollie Wayment
  • Publication number: 20030132125
    Abstract: The subject invention comprises electrochemical methods and devices for in vitro detection of an ischemic event in a patient sample. Following addition of a known amount of a transition metal ion to the patient sample, electrodes are used to measure the current or potential difference of non-sequestered transition metal ion in the sample. The amount of non-sequestered transition metal ion in the sample reflects the degree of modification to albumin that is the result of an ischemic event.
    Type: Application
    Filed: November 26, 2002
    Publication date: July 17, 2003
    Applicant: Ischemia Technologies Inc.
    Inventors: Hollie Wayment, Gary Fagan, Peter A. Crosby, Shannon George